Popular Articles

Oculus Innovative Sciences Receives FDA Clearance For Microcyn(R) Skin And Wound Gel
Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Microcyn® Skin and Wound Gel as both a prescription and over-the-counter formulation. The Rx product, under the supervision of a health care professional, is intended for management of exuding wounds such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgically debrided wounds. This is the first hydrogel product based upon the Microcyn Technology platform and is reimbursable by both Medicare and Medicaid.
generic viagra online download OCR at scanitto.com
First Patient Enrolled In Regeneron And Bayer HealthCare VEGF Trap-Eye Phase 3 Program In Central Retinal Vein Occlusion
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that the first patient has been enrolled in the Phase 3 program of VEGF Trap-Eye for the treatment of central retinal vein occlusion (CRVO), a leading cause of blindness in adults. Regeneron received a $20 million milestone payment from Bayer Healthcare that was triggered by the dosing of the first patient in the CRVO program. Regeneron also announced that enrollment in the Phase 2 DA VINCI study of VEGF Trap-Eye in diabetic macular edema (DME) has been completed and data are expected during the first half of 2010.
accredited caribbean medical schools
News of the day
Cedars-Sinai Women's Heart Center Launches Advanced Preventive Women's Clinic For Women With Menopause Symptoms Who Are At Risk For Heart Disease
Women who are at risk for heart disease and who are also experiencing menopause symptoms now have an added re - a highly specialized clinic in the Division of Cardiology at the Cedars-Sinai Heart Institute. The Advanced Preventive Women"s Clinic at the Women"s Heart Center recently opened and is offering comprehensive cardiac risk assessments designed specifically for women who are in menopause. The clinic also offers menopausal patients state-of-the-art screenings, as well as personalized medicine therapies and counseling, including high-risk hormone counseling.
Mental Health

Canada And China Renew Plan Of Action For Cooperation In Health For 2009-2011

The Honourable Leona Aglukkaq, Minister of Health, and Dr. Chen Zhu, Minister of Health for the People"s Republic of China, today signed a Plan of Action for continued cooperation between the two countries on health priorities of mutual concern. The signing ceremony followed discussions among senior Canadian and Chinese health officials and experts on a range of health issues, including strengthening and reform of health-care systems, primary health care and food safety. "Canada and China have a lot to offer each other in terms of research, regulations and expertise on health-related issues," said Minister Aglukkaq. "The continued sharing of knowledge and insights in priority areas will contribute to the improved health and safety of citizens in both countries." Canada and China are already cooperating on a number of health-related fronts, including regulation of health products and medical research. Today"s signing reinforces and broadens work in areas of common concern, such as emerging and re-emerging infectious diseases and food safety. "China and Canada have a history of longstanding cooperation in health," said Minister Chen. "This 2009-2011 Plan of Action is a symbol of the commitment between Canada and China to continue to cooperate on mutual health issues and challenges to ensure the better health of our future generations." The document being signed today builds on the 2005 to 2008 Plan of Action which promoted cooperation between Canada and China in several areas, including: The timely sharing of information on emerging infectious diseases, such as the H1N1 influenza virus; and A better understanding of regulatory frameworks in the area of therapeutic products and Natural Health Products -- including Traditional Chinese Medicines -- to help ensure the safety and quality of these products. The new Plan of Action also advances the 1995 Memorandum of Understanding relating to health cooperation, and the abilities of Canada and China to further protect and promote health in their respective countries. The Ministers also discussed their support for ongoing educational collaboration, including the Canada-China Norman Bethune Research Scholarships programs, led by the Canadian Institutes of Health Research. These activities help young Canadian and Chinese researchers work together on health issues affecting people in both countries. The Norman Bethune program allows Chinese students to pursue graduate studies with health researchers in Canada. Health Canada


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):